Stratec SE (SBS) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.091x

Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.091x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€21.49 Million ≈ $25.13 Million USD) by net assets (€236.79 Million ≈ $276.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Stratec SE market cap and net worth for the company's overall valuation and market capitalisation.

Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Stratec SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency. Explore SBS cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Crescendo Corporation Bhd
KLSE:6718
0.026x
Shanghai Sanmao Enterprise Group Co Ltd A
SHG:600689
-0.024x
Beacon Minerals Limited
AU:BCN
0.362x
Lightbridge Corporation
F:N7ON
-0.022x
MFS Intermediate Income Trust
NYSE:MIN
0.047x
Wistron Information Technology & Services
TWO:4953
-0.126x
Provident Agro Tbk
JK:PALM
0.279x
Corby Spirit and Wine Limited
TO:CSW-A
-0.088x

Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2025)

The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2025. View SBS live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €237.32 Million
≈ $277.45 Million
€-433.00K
≈ $-506.22K
-0.002x -100.91%
2024-12-31 €242.53 Million
≈ $283.55 Million
€48.71 Million
≈ $56.95 Million
0.201x +141.25%
2023-12-31 €233.33 Million
≈ $272.78 Million
€19.43 Million
≈ $22.71 Million
0.083x +82.38%
2022-12-31 €225.18 Million
≈ $263.26 Million
€10.28 Million
≈ $12.02 Million
0.046x -85.20%
2021-12-31 €205.76 Million
≈ $240.55 Million
€63.47 Million
≈ $74.21 Million
0.308x +67.12%
2020-12-31 €172.54 Million
≈ $201.72 Million
€31.85 Million
≈ $37.23 Million
0.185x +38.04%
2019-12-31 €159.01 Million
≈ $185.90 Million
€21.26 Million
≈ $24.86 Million
0.134x +70.31%
2018-12-31 €152.20 Million
≈ $177.94 Million
€11.95 Million
≈ $13.97 Million
0.079x -58.67%
2017-12-31 €157.84 Million
≈ $184.53 Million
€29.98 Million
≈ $35.05 Million
0.190x +67.93%
2016-12-31 €143.72 Million
≈ $168.02 Million
€16.26 Million
≈ $19.00 Million
0.113x -43.40%
2015-12-31 €130.28 Million
≈ $152.31 Million
€26.03 Million
≈ $30.44 Million
0.200x -43.67%
2014-12-31 €112.05 Million
≈ $131.00 Million
€39.75 Million
≈ $46.47 Million
0.355x +44.63%
2013-12-31 €97.18 Million
≈ $113.61 Million
€23.84 Million
≈ $27.87 Million
0.245x +729.52%
2012-12-31 €91.98 Million
≈ $107.54 Million
€2.72 Million
≈ $3.18 Million
0.030x -77.01%
2011-12-31 €83.23 Million
≈ $97.31 Million
€10.71 Million
≈ $12.52 Million
0.129x +538.58%
2010-12-31 €71.88 Million
≈ $84.03 Million
€1.45 Million
≈ $1.69 Million
0.020x -89.02%
2009-12-31 €59.29 Million
≈ $69.31 Million
€10.88 Million
≈ $12.72 Million
0.183x +95.22%
2008-12-31 €49.90 Million
≈ $58.34 Million
€4.69 Million
≈ $5.48 Million
0.094x -52.28%
2007-12-31 €48.58 Million
≈ $56.79 Million
€9.57 Million
≈ $11.19 Million
0.197x -10.44%
2006-12-31 €40.13 Million
≈ $46.92 Million
€8.83 Million
≈ $10.32 Million
0.220x +430.06%
2005-12-31 €31.52 Million
≈ $36.85 Million
€1.31 Million
≈ $1.53 Million
0.041x -73.32%
2004-12-31 €15.47 Million
≈ $18.08 Million
€2.41 Million
≈ $2.81 Million
0.156x +384.79%
2003-12-31 €12.87 Million
≈ $15.05 Million
€413.00K
≈ $482.84K
0.032x -99.98%
2002-12-31 €11.17K
≈ $13.06K
€1.73 Million
≈ $2.03 Million
155.162x --

About Stratec SE

XETRA:SBS Germany Medical Devices
Market Cap
$341.79 Million
€292.35 Million EUR
Market Cap Rank
#15464 Global
#1500 in Germany
Share Price
€24.05
Change (1 day)
-3.41%
52-Week Range
€16.52 - €32.00
All Time High
€139.81
About

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more